SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications
Diabetes Care
.
2018 Apr;41(4):e47-e49.
doi: 10.2337/dc17-1721.
Epub 2018 Feb 13.
Authors
Emily J Meyer
1
2
3
,
Genevieve Gabb
2
4
,
David Jesudason
5
2
3
Affiliations
1
Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia emily.meyer@sa.gov.au.
2
Discipline of Medicine, University of Adelaide, Adelaide, Australia.
3
Department of Endocrinology and Diabetes, The Queen Elizabeth Hospital, Woodville, Australia.
4
Department of General Medicine, Royal Adelaide Hospital, Adelaide, Australia.
5
Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia.
PMID:
29440112
DOI:
10.2337/dc17-1721
No abstract available
Publication types
Letter